We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Print article
Image: Nova Point-of-Care Capillary Blood Analyzers (Photo courtesy of Nova Biomedical)
Image: Nova Point-of-Care Capillary Blood Analyzers (Photo courtesy of Nova Biomedical)
Nova Biomedical (Waltham, MA, USA) showcased its advanced point-of-care (POC) capillary blood analyzers at MEDLAB Middle East 2021, alongside other products such as POC meters for glucose testing, renal function monitoring and lactate testing.

At this year’s MEDLAB Middle East, Nova exhibited the StatStrip Glucose, which is the only glucose meter cleared by the US FDA for use with critically ill patients, that achieves superior accuracy with no clinical interferences. StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients. Nova also showcased the Stat Profile Prime Plus that combines blood gases, electrolytes, metabolites, CO-Oximetry, and 34 calculated results in a simple, compact critical care blood gas analyzer. Prime Plus combines maintenance-free, component cartridge technology for sensors and reagents with patented, new, maintenance-free, and non-lysing whole blood CO-Oximetry technology.

In addition, Nova showcased Allegro, a compact, point-of-care (POC) analyzer that features a clinically important menu of 10 measured and individually selectable tests, plus seven calculated tests. All tests are measured with disposable, ready-to-use cartridges or test strips, and are easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, which eliminates the need for venipunctures or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro provides rapid results.

Also on display at the event was the EMS Stat, a portable system for A&E use for GLU, KET, LAC, Hb, and HCT testing. Stat EMS can measure lactate, hematocrit, hemoglobin, glucose, and ketone from a capillary blood drop. Results are available in seconds by using single-use biosensors and portable meters. Stat EMS offers simple, fast, and accurate testing in the field. These tests can also help determine the appropriate transport site for patients with trauma, sepsis, or other specialized needs.

Related Links:
Nova Biomedical

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Orienta Tsutsugamushi Test
STANDARD Q Tsutsugamushi IgM/IgG

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.